Greenland Mines Ltd. Common Stock (GRML) Competitors

$0.50 +0.02 (+4.17%)

As of 04:00 PM Eastern

GRML vs. SLGL, REPL, CRBU, WHWK, and ACB

Should you be buying Greenland Mines Ltd. Common Stock stock or one of its competitors? The main competitors of Greenland Mines Ltd. Common Stock include Sol-Gel Technologies (SLGL), Replimune Group (REPL), Caribou Biosciences (CRBU), Whitehawk Therapeutics (WHWK), and Aurora Cannabis (ACB). These companies are all part of the "pharmaceutical products" industry.

How does Greenland Mines Ltd. Common Stock compare to Sol-Gel Technologies?

Sol-Gel Technologies (NASDAQ:SLGL) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.

: 26.2% of Sol-Gel Technologies shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 66.5% of Sol-Gel Technologies shares are held by insiders. Comparatively, 9.9% of Greenland Mines Ltd. Common Stock shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: Sol-Gel Technologies has higher revenue and earnings than Greenland Mines Ltd. Common Stock. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Sol-Gel Technologies $19.39M 10.69 -$6.13M -$2.23 N/A
Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A
: Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -31.60%. Sol-Gel Technologies' return on equity of -24.29% beat Greenland Mines Ltd. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
Sol-Gel Technologies -31.60% -24.29% -18.73%
Greenland Mines Ltd. Common Stock N/A -137.58% -126.00%
: In the previous week, Greenland Mines Ltd. Common Stock had 3 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 3 mentions for Greenland Mines Ltd. Common Stock and 0 mentions for Sol-Gel Technologies. Sol-Gel Technologies' average media sentiment score of 1.95 beat Greenland Mines Ltd. Common Stock's score of 0.00 indicating that Sol-Gel Technologies is being referred to more favorably in the media.
Company Overall Sentiment
Sol-Gel Technologies Very Positive
Greenland Mines Ltd. Common Stock Neutral
: Sol-Gel Technologies presently has a consensus price target of $110.00, suggesting a potential upside of 49.11%. Given Sol-Gel Technologies' stronger consensus rating and higher possible upside, research analysts plainly believe Sol-Gel Technologies is more favorable than Greenland Mines Ltd. Common Stock.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sol-Gel Technologies
0 Sell rating(s)
2 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.33
Greenland Mines Ltd. Common Stock
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Sol-Gel Technologies has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its stock price is 661% more volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sol-Gel Technologies	$19.39M	10.69	-$6.13M	-$2.23	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Company	Net Margins	Return on Equity	Return on Assets
Sol-Gel Technologies	-31.60%	-24.29%	-18.73%
Greenland Mines Ltd. Common Stock	N/A	-137.58%	-126.00%

Company	Overall Sentiment
Sol-Gel Technologies	Very Positive
Greenland Mines Ltd. Common Stock	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sol-Gel Technologies	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Sol-Gel Technologies beats Greenland Mines Ltd. Common Stock on 10 of the 15 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Replimune Group?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Replimune Group (NASDAQ:REPL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

: Replimune Group has a consensus target price of $4.75, indicating a potential upside of 65.51%. Given Replimune Group's stronger consensus rating and higher probable upside, analysts clearly believe Replimune Group is more favorable than Greenland Mines Ltd. Common Stock.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenland Mines Ltd. Common Stock
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Replimune Group
4 Sell rating(s)

6 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.60
: Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Replimune Group, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A
Replimune Group N/A N/A -$247.30M -$3.44 N/A
: 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 92.5% of Replimune Group shares are held by institutional investors. 9.9% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 5.2% of Replimune Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
: In the previous week, Replimune Group had 3 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 6 mentions for Replimune Group and 3 mentions for Greenland Mines Ltd. Common Stock. Replimune Group's average media sentiment score of 0.57 beat Greenland Mines Ltd. Common Stock's score of 0.00 indicating that Replimune Group is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Greenland Mines Ltd. Common Stock
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Replimune Group
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
: Replimune Group's return on equity of -102.69% beat Greenland Mines Ltd. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
Greenland Mines Ltd. Common Stock N/A -137.58% -126.00%
Replimune Group N/A -102.69% -72.22%
: Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its share price is 661% more volatile than the S&P 500. Comparatively, Replimune Group has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Replimune Group	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Replimune Group	N/A	N/A	-$247.30M	-$3.44	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Replimune Group	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-137.58%	-126.00%
Replimune Group	N/A	-102.69%	-72.22%

Summary

Replimune Group beats Greenland Mines Ltd. Common Stock on 8 of the 12 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Caribou Biosciences?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

: Caribou Biosciences has a consensus target price of $8.00, indicating a potential upside of 314.51%. Given Caribou Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Caribou Biosciences is more favorable than Greenland Mines Ltd. Common Stock.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenland Mines Ltd. Common Stock
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Caribou Biosciences
1 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

1 Strong Buy rating(s)
2.75
: Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Caribou Biosciences. Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A
Caribou Biosciences $11.16M 17.07 -$148.12M -$1.59 N/A
: Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its share price is 661% more volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.27, meaning that its share price is 127% more volatile than the S&P 500.
: In the previous week, Greenland Mines Ltd. Common Stock and Greenland Mines Ltd. Common Stock both had 3 articles in the media. Caribou Biosciences' average media sentiment score of 0.00 beat Greenland Mines Ltd. Common Stock's score of 0.00 indicating that Caribou Biosciences is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Greenland Mines Ltd. Common Stock
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Caribou Biosciences
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,327.40%. Caribou Biosciences' return on equity of -78.40% beat Greenland Mines Ltd. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
Greenland Mines Ltd. Common Stock N/A -137.58% -126.00%
Caribou Biosciences -1,327.40% -78.40% -58.68%
: 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 77.5% of Caribou Biosciences shares are held by institutional investors. 9.9% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 8.5% of Caribou Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Caribou Biosciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Caribou Biosciences	$11.16M	17.07	-$148.12M	-$1.59	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Caribou Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-137.58%	-126.00%
Caribou Biosciences	-1,327.40%	-78.40%	-58.68%

Summary

Caribou Biosciences beats Greenland Mines Ltd. Common Stock on 10 of the 15 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Whitehawk Therapeutics?

Whitehawk Therapeutics (NASDAQ:WHWK) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

: Greenland Mines Ltd. Common Stock has lower revenue, but higher earnings than Whitehawk Therapeutics. Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Whitehawk Therapeutics $7.14M 29.15 -$20.60M $0.47 8.96
Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A
: 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. 49.9% of Whitehawk Therapeutics shares are owned by company insiders. Comparatively, 9.9% of Greenland Mines Ltd. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Whitehawk Therapeutics currently has a consensus target price of $7.00, indicating a potential upside of 66.27%. Given Whitehawk Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe Whitehawk Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Whitehawk Therapeutics
1 Sell rating(s)
1 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.50
Greenland Mines Ltd. Common Stock
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Greenland Mines Ltd. Common Stock had 1 more articles in the media than Whitehawk Therapeutics. MarketBeat recorded 3 mentions for Greenland Mines Ltd. Common Stock and 2 mentions for Whitehawk Therapeutics. Whitehawk Therapeutics' average media sentiment score of 1.16 beat Greenland Mines Ltd. Common Stock's score of 0.00 indicating that Whitehawk Therapeutics is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Whitehawk Therapeutics
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Greenland Mines Ltd. Common Stock
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Whitehawk Therapeutics' return on equity of -62.88% beat Greenland Mines Ltd. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
Whitehawk Therapeutics N/A -62.88% -58.98%
Greenland Mines Ltd. Common Stock N/A -137.58% -126.00%
: Whitehawk Therapeutics has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 7.61, meaning that its stock price is 661% more volatile than the S&P 500.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Whitehawk Therapeutics	$7.14M	29.15	-$20.60M	$0.47	8.96
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Whitehawk Therapeutics	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Whitehawk Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Whitehawk Therapeutics	N/A	-62.88%	-58.98%
Greenland Mines Ltd. Common Stock	N/A	-137.58%	-126.00%

Summary

Whitehawk Therapeutics beats Greenland Mines Ltd. Common Stock on 11 of the 14 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Aurora Cannabis?

Aurora Cannabis (NASDAQ:ACB) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

: Aurora Cannabis has higher revenue and earnings than Greenland Mines Ltd. Common Stock. Aurora Cannabis is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aurora Cannabis $373.12M 0.54 $1.63M -$1.08 N/A
Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A
: 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 9.9% of Greenland Mines Ltd. Common Stock shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
2.00
Greenland Mines Ltd. Common Stock
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, Greenland Mines Ltd. Common Stock had 1 more articles in the media than Aurora Cannabis. MarketBeat recorded 3 mentions for Greenland Mines Ltd. Common Stock and 2 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.25 beat Greenland Mines Ltd. Common Stock's score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Greenland Mines Ltd. Common Stock
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Aurora Cannabis has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 7.61, indicating that its share price is 661% more volatile than the S&P 500.
: Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Greenland Mines Ltd. Common Stock's return on equity.
Company Net Margins Return on Equity Return on Assets
Aurora Cannabis -23.46% -0.04% -0.03%
Greenland Mines Ltd. Common Stock N/A -137.58% -126.00%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurora Cannabis	$373.12M	0.54	$1.63M	-$1.08	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aurora Cannabis	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aurora Cannabis	-23.46%	-0.04%	-0.03%
Greenland Mines Ltd. Common Stock	N/A	-137.58%	-126.00%

Summary

Aurora Cannabis beats Greenland Mines Ltd. Common Stock on 8 of the 14 factors compared between the two stocks.

Get Greenland Mines Ltd. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRML vs. The Competition

Export

Metric	Greenland Mines Ltd. Common Stock	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$60.62M	$3.10B	$6.25B	$11.87B
Dividend Yield	N/A	1.91%	2.73%	5.21%
P/E Ratio	-1.56	18.37	29.04	28.47
Price / Sales	N/A	281.31	476.61	60.94
Price / Cash	N/A	50.43	27.62	36.52
Price / Book	3.85	4.33	9.67	6.67
Net Income	-$10.55M	$72.19M	$3.55B	$332.53M
7 Day Performance	10.86%	2.02%	1.70%	2.01%
1 Month Performance	N/A	6.41%	5.62%	9.20%
1 Year Performance	194.12%	37.73%	34.42%	39.59%

Greenland Mines Ltd. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRML Greenland Mines Ltd. Common Stock	0.0977 of 5 stars	$0.50 +4.2%	N/A	N/A	$60.62M	N/A	N/A	5	News Coverage Analyst Upgrade Gap Up
SLGL Sol-Gel Technologies	2.2385 of 5 stars	$71.02 +0.1%	$110.00 +54.9%	N/A	$203.44M	$19.39M	N/A	50
REPL Replimune Group	3.2051 of 5 stars	$2.44 -5.0%	$4.75 +94.5%	N/A	$201.07M	N/A	N/A	210
CRBU Caribou Biosciences	1.8688 of 5 stars	$1.97 -5.5%	$8.00 +307.1%	N/A	$193.91M	$11.16M	N/A	100	News Coverage Positive News
WHWK Whitehawk Therapeutics	4.0714 of 5 stars	$4.09 -0.9%	$7.00 +71.1%	N/A	$193.28M	$7.14M	8.71	21

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GRML) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. SLGL, REPL, CRBU, WHWK, and ACB

How does Greenland Mines Ltd. Common Stock compare to Sol-Gel Technologies?

Summary

How does Greenland Mines Ltd. Common Stock compare to Replimune Group?

Summary

How does Greenland Mines Ltd. Common Stock compare to Caribou Biosciences?

Summary

How does Greenland Mines Ltd. Common Stock compare to Whitehawk Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Aurora Cannabis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. SLGL, REPL, CRBU, WHWK, and ACB

How does Greenland Mines Ltd. Common Stock compare to Sol-Gel Technologies?

Summary

How does Greenland Mines Ltd. Common Stock compare to Replimune Group?

Summary

How does Greenland Mines Ltd. Common Stock compare to Caribou Biosciences?

Summary

How does Greenland Mines Ltd. Common Stock compare to Whitehawk Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Aurora Cannabis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools